Artifact Details

Description

Tony Evnin joined Venrock in 1974 and established the firm’s healthcare franchise. He helped shape the modern biotechnology industry, building valuable companies that address some of the important medical needs of the world. Among the companies he helped build are: Centocor, IDEC Pharmaceutical, Infinity Pharmaceuticals, Genetics Institute, and IDEXX laboratories. Six of Tony’s portfolio companies have entered the public market in the last three years and over twenty-nine of his investments have been through an IPO during his Venrock tenure.

Tony started his career as a research scientist and group leader in organic chemistry at Union Carbide and as director of product development at Story Chemical. Today, he serves as Trustee Emeritus of Princeton University, as a Trustee of The Rockefeller University, and as a member of the Board of Overseers of Memorial Sloan-Kettering Cancer Center. In 2009 he received the Lifetime Achievement Award from the National Venture Capital Association. It has been noted that Tony not only helped shape the venture model for the life sciences industry, but he also mentored a new generation of venture capitalists.

Tony holds a Ph.D. in Chemistry from the Massachusetts Institute of Technology and an A.B. in Chemistry from Princeton University.

Date

2009-06

Contributor

Evnin, Anthony B., Interviewee

Kolker, Carole, Interviewer

Publisher

National Venture Capital Association (NVCA)

Extent

92 p.

Format

PDF

Category

Transcription

Collection Title

NVCA-Venture Forward Oral History Collection

Credit

Gift of National Venture Capital Association

Lot Number

X8628.2018

Related Records

102740516

Evnin, Anthony B. oral history